🇺🇸 OGN — Organon & Co.

Salud Mantener
← Volver

Precio actual

13,85 USD

Máx. histórico

39,36

1707 días

Caída desde máximo

-64,81%

Rango 52 semanas

5,69 – 13,85

Variación hoy

+0,22%

Cierre anterior

13,82

Rango de hoy

13,83 – 13,85

Volumen hoy

3.657.869

Peor caída histórica

-82,69%

02/03/2022 → 30/03/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

46,97%

Información
Nombre completo
Organon & Co.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
10.000
PER ⓘ
17,76 (puede no estar actualizado)
Dividend yield
0,58% (puede no estar actualizado)
Precio objetivo analistas
10,33 USD (puede no estar actualizado)
Primera cotización
14/05/2021
Precio actualizado
hace 22 horas
Sobre la empresa

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

Dividendos repartidos Total últimos 12 meses: 0,0800 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/08/2026 0,0200 USD
11/05/2026 0,0200 USD
23/02/2026 0,0200 USD
20/11/2025 0,0200 USD
15/08/2025 0,0200 USD
12/05/2025 0,0200 USD
24/02/2025 0,2800 USD
12/11/2024 0,2800 USD
16/08/2024 0,2800 USD
10/05/2024 0,2800 USD
23/02/2024 0,2800 USD
10/11/2023 0,2800 USD
17/08/2023 0,2800 USD
12/05/2023 0,2800 USD
24/02/2023 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 14,20 14,57 14,13 14,29 -0,42% 3,13% 4.038.300
03/03/2025 15,04 15,07 14,22 14,35 -3,76% 5,65% 5.021.900
28/02/2025 15,08 15,22 14,75 14,91 -0,86% 3,13% 4.600.200
27/02/2025 15,27 15,44 14,97 15,04 -2,84% 3,11% 2.718.000
26/02/2025 16,04 16,12 15,39 15,48 -4,03% 4,58% 2.909.100
25/02/2025 15,20 16,18 15,13 16,13 +6,96% 6,91% 4.443.300
24/02/2025 15,29 15,41 15,05 15,08 -2,65% 2,35% 2.174.700
21/02/2025 15,74 15,74 15,32 15,49 -1,27% 2,67% 3.553.000
20/02/2025 15,42 15,90 15,42 15,69 +2,62% 3,15% 2.212.900
19/02/2025 15,39 15,67 15,26 15,29 -1,23% 2,66% 3.194.900
18/02/2025 15,66 15,75 15,30 15,48 +1,31% 2,91% 3.415.000
14/02/2025 16,14 16,50 15,25 15,28 -6,37% 7,74% 4.425.600
13/02/2025 15,74 17,23 15,00 16,32 +11,02% 14,17% 8.157.200
12/02/2025 14,84 15,10 14,68 14,70 -1,67% 2,80% 3.981.100
11/02/2025 14,88 15,00 14,83 14,95 -0,60% 1,14% 1.704.100
10/02/2025 14,70 15,06 14,66 15,04 +2,87% 2,72% 2.564.100
07/02/2025 14,90 14,96 14,53 14,62 -1,81% 2,89% 2.562.700
06/02/2025 15,36 15,41 14,84 14,89 -2,62% 3,71% 2.204.000
05/02/2025 15,01 15,36 14,71 15,29 +2,34% 4,33% 2.555.600
04/02/2025 14,94 15,12 14,85 14,94 +0,20% 1,81% 2.435.000
03/02/2025 15,17 15,47 14,82 14,91 -4,18% 4,28% 3.147.500
31/01/2025 15,90 15,97 15,56 15,56 -2,57% 2,58% 2.783.300
30/01/2025 16,01 16,17 15,87 15,97 +0,82% 1,87% 1.688.700
29/01/2025 16,06 16,22 15,77 15,84 -1,37% 2,80% 1.659.000
28/01/2025 16,25 16,62 16,01 16,06 -1,23% 3,78% 2.025.700
27/01/2025 15,99 16,28 15,86 16,26 +1,82% 2,63% 2.532.900
24/01/2025 16,37 16,40 15,95 15,97 -2,68% 2,77% 2.174.800
23/01/2025 15,84 16,43 15,82 16,41 +3,40% 3,85% 2.104.300
22/01/2025 15,79 15,97 15,75 15,87 -0,06% 1,39% 1.863.400
21/01/2025 15,85 15,96 15,29 15,88 +0,89% 4,25% 2.785.800